Loading viewer...
investor_presentation
Format: PDF investor_presentation
ImmuCell Corporation (NASDAQ: ICCC) presents its business overview, strategic opportunities, and financial performance for April 2024. The presentation covers company operations, product development including First Defense and Re-Tain product lines, manufacturing capacity expansion, and market positioning in animal health.
investor_presentation
52 Pages
investor_presentation
53 Pages
Intel
Legend Biotech Investor Presentation — December 2021
investor_presentationinvestor_presentation
33 Pages
Legend Biotech Corporation